XML 28 R11.htm IDEA: XBRL DOCUMENT
v3.20.2

Employee Stock Plans | 12 Months Ended
--- | ---
Apr. 30, 2020
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract] |
Employee Stock Plans | 4. Employee Stock Plans Stock-Based Compensation The following table summarizes the components of stock-based compensation expense recognized in the Company’s consolidated statements of income for the periods indicated:
|  | Year Ended April 30, |
|  | 2020 |  |  | 2019 |  |  | 2018 |
|  | (in thousands) |
Restricted stock |  | $ | 21,495 |  |  | $ | 22,063 |  |  | $ | 20,282 |
ESPP |  |  | 1,323 |  |  |  | 1,322 |  |  |  | 1,187 |
Total stock-based compensation expense, pre-tax |  |  | 22,818 |  |  |  | 23,385 |  |  |  | 21,469 |
Tax benefit from stock-based compensation expense |  |  | (6,642 | ) |  |  | (5,155 | ) |  |  | (7,319 | )
Total stock-based compensation expense, net of tax |  | $ | 16,176 |  |  | $ | 18,230 |  |  | $ | 14,150 |
Stock Incentive Plan At the Company’s 2019 Annual Meeting of Stockholders, held on October 3, 2019, the Company’s stockholders approved an amendment and restatement to the Korn Ferry Amended and Restated 2008 Stock Incentive Plan (the 2019 amendment and restatement being the “Fourth A&R 2008 Plan”), which, among other things, eliminated the fungible share counting provision and decreased the total number of shares of the Company’s common stock available for stock-based awards by 2,141,807 shares, leaving 3,600,000 shares available for issuance, subject to certain changes in the Company’s capital structure and other extraordinary events. The Fourth A&R 2008 Plan was also amended to generally require a minimum one-year vesting for all future awards, and provides for the grant of awards to eligible participants, designated as either nonqualified or incentive stock options, restricted stock and restricted stock units, any of which are market-based, and incentive bonuses, which may be paid in cash or stock or a combination thereof. Restricted Stock The Company grants time-based restricted stock awards to executive officers and other senior employees generally vesting over a four-year period. In addition, certain key management members typically receive time-based restricted stock awards upon commencement of employment and may receive them annually in conjunction with the Company’s performance review. Time-based restricted stock awards are granted at a price equal to fair value, which is determined based on the closing price of the Company’s common stock on the grant date. The Company recognizes compensation expense for time-based restricted stock awards on a straight-line basis over the vesting period. The Company also grants market-based and performance-based restricted stock units to executive officers and other senior employees. The market-based units vest after three years depending upon the Company’s total stockholder return over the three-year performance period relative to other companies in its selected peer group. The fair value of these market-based restricted stock units are determined by using extensive market data that is based on historical Company and peer group information. The Company recognizes compensation expense for market-based restricted stock units on a straight-line basis over the vesting period. Performance-based restricted stock units vest after three years, depending upon the Company meeting certain objectives that are set at the time the restricted stock unit is issued. Performance-based restricted stock units are granted at a price equal to fair value, which is determined based on the closing price of the Company’s common stock on the grant date. At the end of each reporting period, the Company estimates the number of restricted stock units expected to vest, based on the probability that certain performance objectives will be met, exceeded, or fall below target levels, and the Company takes into account these estimates when calculating the expense for the period. As of April 30, 2020 and 2019, no performance-based shares were outstanding. Restricted stock activity is summarized below:
|  | April 30, |
|  | 2020 |  |  | 2019 |  |  | 2018 |
|  | Shares |  |  | Weighted- Average Grant Date Fair Value |  |  | Shares |  |  | Weighted- Average Grant Date Fair Value |  |  | Shares |  |  | Weighted- Average Grant Date Fair Value |
|  | (in thousands, except per share data) |
Non-vested, beginning of year |  |  | 1,460 |  |  | $ | 38.42 |  |  |  | 1,730 |  |  | $ | 33.45 |  |  |  | 1,581 |  |  | $ | 29.74 |
Granted |  |  | 608 |  |  | $ | 38.38 |  |  |  | 671 |  |  | $ | 40.93 |  |  |  | 650 |  |  | $ | 37.60 |
Vested |  |  | (638 | ) |  | $ | 25.42 |  |  |  | (904 | ) |  | $ | 36.41 |  |  |  | (431 | ) |  | $ | 26.13 |
Forfeited |  |  | (65 | ) |  | $ | 33.48 |  |  |  | (37 | ) |  | $ | 32.26 |  |  |  | (70 | ) |  | $ | 33.26 |
Non-vested, end of year |  |  | 1,365 |  |  | $ | 44.59 |  |  |  | 1,460 |  |  | $ | 38.42 |  |  |  | 1,730 |  |  | $ | 33.45 |
As of April 30, 2020, there were 0.5 million shares outstanding relating to market-based restricted stock units with total unrecognized compensation totaling $10.5 million. As of April 30, 2020, there was $34.7 million of total unrecognized compensation cost related to all non-vested awards of restricted stock, which is expected to be recognized over a weighted-average period of 2.3 years. During fiscal 2020 and 2019, 232,618 shares and 356,879 shares of restricted stock totaling $9.0 million and $20.7 million, respectively, were repurchased by the Company, at the option of the employee, to pay for taxes related to the vesting of restricted stock. Employee Stock Purchase Plan The Company has an ESPP that, in accordance with Section 423 of the Internal Revenue Code, allows eligible employees to authorize payroll deductions of up to 15% of their salary to purchase shares of the Company’s common stock at 85% of the fair market price of the common stock on the last day of the enrollment period. Employees may not purchase more than $25,000 in stock during any calendar year. The maximum number of shares that may be issued under the ESPP is 3.0 million shares. During fiscal 2020, 2019, and 2018, employees purchased 220,161 shares at $34.90 per share, 169,299 shares at $42.05 per share and 198,749 shares at $31.77 per share, respectively. As of April 30, 2020, the ESPP had approximately 0.7 million shares remaining available for future issuance. Common Stock During fiscal 2020, there were no stock options exercised. During fiscal 2019 and 2018, the Company issued 6,720 shares and 41,075 shares of common stock, respectively, because of the exercise of stock options, with cash proceeds from the exercise of $0.2 million and $0.6 million, respectively. During fiscal 2020, 2019 and 2018, the Company repurchased (on the open market or privately negotiated transactions) 2,606,861 shares, 809,074 shares and 984,079 shares, respectively, of the Company’s common stock for $92.4 million $37.4 million and $33.1 million, respectively.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration